A retrospective study of diagnosis and treatment of chronic obstructive pulmonary disease in patients with primary bronchogenic carcinoma of lung
Aiben Huang,Bei He,Li Pang,Yanwen Jiang,Qiuhong Fang
DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2016.015.001
2016-01-01
Abstract:Objective To investigate the clinical characteristics,diagnosis and therapy of chronic obstructive pulmonary disease (COPD) complicating with primary bronchogenic carcinoma of lung to guide the clinical diagnosis and treatment.Methods 198 patients with lung cancer hospitalized in Beijing Shijitan Hospital affiliated to Capital Medical University From January 2009 to October 2010 were divided into COPD group (n =59) and non COPD group (n =139).The clinical features,diagnosis and treatment were retrospectively analyzed.Results There was no statistical significance in gender (P =0.074),age (t =0.06,P =0.946),smoking index (P =1.000),tumor differentiation (x2 =1.942,P =0.378),treatment method (P =0.211) and mortality within 30 days after surgery (P =0.138) betweenthe two groups.Compared to non-COPD group,vital capacity (t =2.492,P =0.015),forced vital capacity (FVC) (t =2.522,P =0.013),forced expiratory volume in one second (FEV1) (t =5.450,P＜0.001),FEV1/FVC (t =6.040,P＜0.001),FEV1％pred (t =10.20,P＜0.001) and proportion of patients with lung adenocarcinoma (P =0.041) in COPD group were lower.Compared to non COPD group,proportion of patients with lung squamous cell carcinoma (P =0.001),clinical stage Ⅲ(P =0.001),previous respiratory symptoms (P ＜ 0.001),hospitalization time (t =18.95,P ＜0.001) and incidence of operation complications (P =0.016) in COPD group were higher.According to global initiative for chronic obstructive lung disease (GOLD) lung function classification standard,the patients in COPD group were divided into (GOLD Ⅰ +GOLD Ⅱ) group (n =40) and (GOLD Ⅲ +GOLD Ⅳ) group (n =10).There was no statistical significance in gender (P =0.704),age (t =1.057,P =0.296),smoking history (P =0.671),pathological type (x2 =4.828,P =0.089),clinical staging (P =0.659) and treatment method (P =0.494) between the two groups.The incidence of operation complications (P ＜0.003) and mortality within 30 days after surgery (P =0.041) in (GOLD Ⅲ +GOLD Ⅳ) group were higher than those in (GOLD Ⅰ +GOLD]) group.Only 16 cases (27.1％) were diagnosed as COPD with lung cancer when admitted to the hospital.During hospitalization,only 15 cases (25.4％) were treated with bronchodilator and budesonide in the short term.24 cases (40.7％) were diagnosed as COPD with lung cancer when discharged.Only 15 cases (25.4％) regularly took longacting bronchodilator/inhaled steroids or long-acting muscarinic antagonist.Conclusions Lung cancer combined with COPD is not rare,but missed diagnosis rate in clinic is high,and the treatment is not standardized.Compared with non-COPD group,respiratory system symptoms are more obvious,proportion of patients with squamous cell carcinoma is higher,proportion of patients with adenocarcinoma is lower,proportion of patients with clinical stage Ⅲ is higher,pulmonary function is worse,hospitalization time is longer,and postoperative complications are more in COPD group.The incidence of operation complications and mortality within 30 days after surgery in (GOLD Ⅲ +GOLD Ⅳ) group are higher than those in (GOLD Ⅰ +GOLD Ⅱ) group.Early detection and standard treatment of COPD are important in the treatment of patients with lung cancer.